MKI67 and neoplasm: In addition, the xenograft tumor formation experiment verified that MLN4924 administration repressed tumor growth and enhanced tumor cell sensitivity to DDP (Fig. 6K–N), as evidenced by the increased positive p27 and CC3, while decreasing Ki67, IHC staining ratios with or without DDP treatment (Fig. S6F–G).